{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:07:47Z","timestamp":1777388867677,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.nmd.2017.03.005","type":"journal-article","created":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T15:15:17Z","timestamp":1489158917000},"page":"550-556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Targeted population screening of late onset Pompe disease in unspecified myopathy patients for Korean population"],"prefix":"10.1016","volume":"27","author":[{"given":"Jung Hwan","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Hong","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung Jun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sook Za","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Mi","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Kyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae-Seong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Chul","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2017.03.005_bib0010","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe's disease","volume":"372","author":"van der Ploeg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.nmd.2017.03.005_bib0015","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","article-title":"A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease","volume":"148","author":"Kishnani","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.nmd.2017.03.005_bib0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nmd.2012.09.004","article-title":"Presymptomatic late-onset Pompe disease identified by the dried blood spot test","volume":"23","author":"Wagner","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2017.03.005_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2011.02.004","article-title":"Pompe disease: design, methodology, and early findings from the Pompe registry","volume":"103","author":"Byrne","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2017.03.005_bib0030","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/2013.jamaneurol.486","article-title":"Diagnosis of Pompe disease: muscle biopsy vs blood-based assays","volume":"70","author":"Vissing","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nmd.2017.03.005_bib0035","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00415-005-0922-9","article-title":"The natural course of non-classic Pompe's disease: a review of 225 published cases","volume":"252","author":"Winkel","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2017.03.005_bib0040","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/ajmg.a.36110","article-title":"Timing of diagnosis of patients with Pompe disease: data from the Pompe registry","volume":"161A","author":"Kishnani","year":"2013","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.nmd.2017.03.005_bib0045","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe's disease","volume":"362","author":"van der Ploeg","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2017.03.005_bib0050","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2017.03.005_bib0055","doi-asserted-by":"crossref","first-page":"e1116","DOI":"10.1542\/peds.2008-3667","article-title":"Pompe disease in infants: improving the prognosis by newborn screening and early treatment","volume":"124","author":"Chien","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.nmd.2017.03.005_bib0060","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1542\/peds.2007-2222","article-title":"Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program","volume":"122","author":"Chien","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.nmd.2017.03.005_bib0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.ejhg.5201044","article-title":"Prevalence of lysosomal storage diseases in Portugal","volume":"12","author":"Pinto","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2017.03.005_bib0070","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/sj.ejhg.5200367","article-title":"Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling","volume":"7","author":"Ausems","year":"1999","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2017.03.005_bib0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/(SICI)1096-8628(19980827)79:1<69::AID-AJMG16>3.0.CO;2-K","article-title":"Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease","volume":"79","author":"Martiniuk","year":"1998","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.nmd.2017.03.005_bib0080","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jns.2006.09.012","article-title":"Two new missense mutations of GAA in late onset glycogen storage disease type II","volume":"251","author":"Park","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2017.03.005_bib0085","first-page":"311","article-title":"Three patients with glycogen storage disease type II and the mutational spectrum of GAA in Korean patients","volume":"43","author":"Park","year":"2013","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.nmd.2017.03.005_bib0090","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/0883073811420295","article-title":"Infantile Pompe disease: clinical and genetic characteristics with an experience of enzyme replacement therapy","volume":"27","author":"Cho","year":"2012","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nmd.2017.03.005_bib0095","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3345\/kjp.2007.50.2.213","article-title":"Clinical improvement in a case of atypical infantile onset Pompe disease with enzyme replacement therapy","volume":"50","author":"Jeon","year":"2007","journal-title":"Korean J Pediatr"},{"key":"10.1016\/j.nmd.2017.03.005_bib0100","first-page":"71","article-title":"Hypertrophic cardiomyopathy in Pompe disease is not limited to the classic infantile-onset phenotype","volume":"17","author":"Lee","year":"2014","journal-title":"JIMD Rep"},{"key":"10.1016\/j.nmd.2017.03.005_bib0105","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10072-014-2000-5","article-title":"Effect of enzyme replacement therapy in late onset Pompe disease: open pilot study of 48 weeks follow-up","volume":"36","author":"Park","year":"2015","journal-title":"Neurol Sci"},{"key":"10.1016\/j.nmd.2017.03.005_bib0110","first-page":"250","article-title":"Use of tandem mass spectrometry for newborn screening of 6 lysosomal storage disorders in a Korean population","volume":"31","author":"Han","year":"2011","journal-title":"Korean J Lab Med"},{"key":"10.1016\/j.nmd.2017.03.005_bib0115","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/01.gim.0000217785.19262.9e","article-title":"The use of acarbose inhibition in the measurement of acid alpha-glucosidase activity in blood lymphocytes for the diagnosis of Pompe disease","volume":"8","author":"Jack","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.nmd.2017.03.005_bib0120","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ymgme.2005.10.016","article-title":"A new diagnostic assay for glycogen storage disease type II in mixed leukocytes","volume":"88","author":"Okumiya","year":"2006","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2017.03.005_bib0125","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ymgme.2013.08.005","article-title":"Late-onset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies","volume":"110","author":"Preisler","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2017.03.005_bib0130","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ymgme.2013.03.002","article-title":"Screening for later-onset Pompe's disease in patients with paucisymptomatic hyperCKemia","volume":"109","author":"Spada","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2017.03.005_bib0135","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.nmd.2014.06.438","article-title":"Screening for late-onset Pompe disease in Finland","volume":"24","author":"Palmio","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2017.03.005_bib0140","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.nmd.2015.04.008","article-title":"Targeted screening for the detection of Pompe disease in patients with unclassified limb-girdle muscular dystrophy or asymptomatic hyperCKemia using dried blood: a Spanish cohort","volume":"25","author":"Gutierrez-Rivas","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2017.03.005_bib0145","first-page":"5","article-title":"LOPED study: looking for an early diagnosis in a late-onset Pompe disease high-risk population","volume":"87","author":"Musumeci","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2017.03.005_bib0150","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1212\/WNL.0000000000002758","article-title":"Prevalence of Pompe disease in 3,076 patients with hyperCKemia and limb-girdle muscular weakness","volume":"87","author":"Lukacs","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2017.03.005_bib0155","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/jhg.2009.66","article-title":"Silent exonic mutation in the acid-[alpha]-glycosidase gene that causes glycogen storage disease type II by affecting mRNA splicing","volume":"54","author":"Maimaiti","year":"2009","journal-title":"J Hum Genet"},{"key":"10.1016\/j.nmd.2017.03.005_bib0160","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1002\/humu.20745","article-title":"Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating","volume":"29","author":"Kroos","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2017.03.005_bib0165","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00415-008-0714-0","article-title":"Identification of eight novel mutations of the acid alpha-glucosidase gene causing the infantile or juvenile form of glycogen storage disease type II","volume":"255","author":"Wan","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2017.03.005_bib0170","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12881-014-0141-2","article-title":"Clinical and GAA gene mutation analysis in mainland Chinese patients with late-onset Pompe disease: identifying c.2238G>C as the most common mutation","volume":"15","author":"Liu","year":"2014","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.nmd.2017.03.005_bib0175","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/ejhg.2008.34","article-title":"p.[G576S; E689K]: pathogenic combination or polymorphism in Pompe disease?","volume":"16","author":"Kroos","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2017.03.005_bib0180","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ymgme.2009.12.014","article-title":"Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program","volume":"99","author":"Labrousse","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2017.03.005_bib0185","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ymgme.2012.04.013","article-title":"Algorithm for Pompe disease newborn screening: results from the Taiwan screening program","volume":"106","author":"Chiang","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2017.03.005_bib0190","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ymgme.2009.03.004","article-title":"High frequency of acid alpha-glucosidase pseudodeficiency complicates newborn screening for glycogen storage disease type II in the Japanese population","volume":"97","author":"Kumamoto","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2017.03.005_bib0195","first-page":"78","article-title":"Early is better? A new algorithm for early diagnosis in late onset Pompe disease (LOPD)","volume":"32","author":"Toscano","year":"2013","journal-title":"Acta Myol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896617300275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896617300275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:05:34Z","timestamp":1760774734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896617300275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0960896617300275"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2017.03.005","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted population screening of late onset Pompe disease in unspecified myopathy patients for Korean population","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2017.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}